Document: Questions and answers (Q&As) on the external guidance of Policy 0070 on clinical data publication (CDP)-2025/7/23

Document: Marketing authorisation application (MAA) - pre-submission interactions form-2025/7/23

Document: New fee regulation: General questions and answers for all applicants-2025/7/23

Document: Anti-t lymphocyte immunoglobulin for human use, rabbit : List of nationally authorised medicinal products - PSUSA/00010252/202406-2025/7/23

Document: Agenda - PDCO agenda of the 22-25 July 2025 meeting-2025/7/22

Document: Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 23 July 2025-2025/7/22

Document: Network Data Steering Group workplan 2025-2028-2025/7/22

Document: Medicinal products for human use: monthly figures - June 2025-2025/7/22

Page: Requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD) - Scientific guideline-2025/7/21

Document: Guideline on the requirements for demonstrating therapeutic equivalence between orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD) - Revision 2-2025/7/21